[1] Kapp A, Piskorski A, Schopf E. Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis. Br J Dermatol, 1988, 119:707.
[2] Kemmett D, Symons JA. Colver GB, et al. Serum soluble interleukin 2 receptor in psoriasis; Failure to reflect clinical improvement. Acta Derm Venereol Stockh, 1990, 70:264.
[3] Kapp A, Neuner P, Krutmann J, et al. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis; Comparison with serum interleukin-2 receptor levels. Acta Derm Venereol Stockh,1991,71:403.
[4] Salvarain C, Macchioni P, Boiardi L, et al. Low dose cyclosporine A in psoriatic arthritis:relation between soluble interleukin 2 receptors and response to therapy. J Rheumatol, 1992. 19:74.
[5] Snellman E, Lauharanta J, Reunanen A, et al. Effect of heliotherapy on skin and joint symptoms in psoriasis:a 6-month follow-up study. Br J Dermatol, 1993, 128:172.
[6] Duncan JI, Horrocks C, Ormerod AD, et al. Soluble IL-2 receptor and CD25 cells in psoriasis:effects of cyclosporin A and PUVA therapy. Clin Exp Immunol, 1991,85:293. |